FI864431L - Foerfarande foer framstaellning av dopamin- -hydroxylasinhibitorer. - Google Patents

Foerfarande foer framstaellning av dopamin- -hydroxylasinhibitorer. Download PDF

Info

Publication number
FI864431L
FI864431L FI864431A FI864431A FI864431L FI 864431 L FI864431 L FI 864431L FI 864431 A FI864431 A FI 864431A FI 864431 A FI864431 A FI 864431A FI 864431 L FI864431 L FI 864431L
Authority
FI
Finland
Prior art keywords
hydroxylasinhibitorer
dopamin
foerfarande foer
foer framstaellning
framstaellning
Prior art date
Application number
FI864431A
Other languages
English (en)
Finnish (fi)
Other versions
FI864431A7 (fi
FI864431A0 (fi
Inventor
Carl Kaiser
Lawrence Ivan Kruse
Stephen Torey Ross
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of FI864431A0 publication Critical patent/FI864431A0/fi
Publication of FI864431L publication Critical patent/FI864431L/fi
Publication of FI864431A7 publication Critical patent/FI864431A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI864431A 1985-10-31 1986-10-30 Menetelmä dopamiini- -hydroksylaasin inhibiittoreiden valmistamiseksi. FI864431A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/793,512 US4719223A (en) 1985-10-31 1985-10-31 Imidazolethiol dopamine-beta-hydroxylase inhibitors

Publications (3)

Publication Number Publication Date
FI864431A0 FI864431A0 (fi) 1986-10-30
FI864431L true FI864431L (fi) 1987-05-01
FI864431A7 FI864431A7 (fi) 1987-05-01

Family

ID=25160082

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864431A FI864431A7 (fi) 1985-10-31 1986-10-30 Menetelmä dopamiini- -hydroksylaasin inhibiittoreiden valmistamiseksi.

Country Status (15)

Country Link
US (1) US4719223A (da)
EP (1) EP0221778A3 (da)
JP (1) JPS62108815A (da)
KR (1) KR870003994A (da)
CN (1) CN86107151A (da)
AU (1) AU598485B2 (da)
DK (1) DK515786A (da)
FI (1) FI864431A7 (da)
HU (1) HU197563B (da)
NO (1) NO864337L (da)
NZ (1) NZ218098A (da)
PH (1) PH21776A (da)
PT (1) PT83628B (da)
ZA (1) ZA868269B (da)
ZW (1) ZW21586A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
US5057613A (en) * 1986-05-06 1991-10-15 Merrell Dow Pharmaceuticals Novel thione dopamine beta hydroxylase inhibitors
US4859779A (en) * 1987-03-24 1989-08-22 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
US4835154A (en) * 1987-06-01 1989-05-30 Smithkline Beckman Corporation 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
DE19620408A1 (de) * 1996-05-21 1997-11-27 Bayer Ag Mercapto-imidazolyl-Derivate
US20080002735A1 (en) * 1997-04-01 2008-01-03 Paradox Security Systems Ltd. Device network
US7965734B2 (en) * 2005-12-15 2011-06-21 Paradox Security Systems Ltd. Device network interface
IN2012DE00661A (da) 2012-03-07 2015-08-21 Univ Delhi
CN103214421B (zh) * 2012-12-11 2016-03-02 上海博康精细化工有限公司 2-巯基-1-甲基咪唑的工业化生产方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2180772A (en) * 1935-10-25 1939-11-21 Gen Aniline Works Inc Trifluoromethyl benzaldehydes
GB1155580A (en) * 1965-10-21 1969-06-18 Geigy Ag J R New Imidazole Derivatives their Production and Use
DE2259627A1 (de) * 1972-12-06 1974-06-12 Hoechst Ag Imidazolyl-(2)-thio-alkansaeureester und verfahren zu ihrer herstellung
MC1173A1 (fr) * 1976-12-20 1978-09-25 Wellcome Found Imidazolines et leur emploi comme agents pesticides
US4284641A (en) * 1977-08-26 1981-08-18 Burroughs Wellcome Co. Pharmaceutically active imidazole derivatives
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
US4487761A (en) * 1982-04-05 1984-12-11 Merck & Co., Inc. Dopamine β-hydroxylase inhibitors
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives

Also Published As

Publication number Publication date
NZ218098A (en) 1989-07-27
CN86107151A (zh) 1987-05-13
PT83628A (en) 1986-11-01
PH21776A (en) 1988-02-24
EP0221778A3 (en) 1988-03-23
JPS62108815A (ja) 1987-05-20
NO864337L (no) 1987-05-04
AU598485B2 (en) 1990-06-28
HUT43830A (en) 1987-12-28
FI864431A7 (fi) 1987-05-01
NO864337D0 (no) 1986-10-30
EP0221778A2 (en) 1987-05-13
KR870003994A (ko) 1987-05-06
PT83628B (en) 1988-11-15
DK515786A (da) 1987-05-01
AU6463986A (en) 1987-05-07
HU197563B (en) 1989-04-28
US4719223A (en) 1988-01-12
FI864431A0 (fi) 1986-10-30
DK515786D0 (da) 1986-10-28
ZW21586A1 (en) 1987-06-24
ZA868269B (en) 1987-07-29

Similar Documents

Publication Publication Date Title
FI862707A0 (fi) Foerfarande foer framstaellning av kvaeveoxid.
FI863275L (fi) Foerfarande foer syntetisering av mg0-a1203-si02-glas och -keramik.
FI862606A0 (fi) Foerfarande foer framstaellning av citrusaromkompositioner.
FI862855A7 (fi) Foerbaettrat trycksystem foer manschett foer maetning av blodtryck.
FI862794A0 (fi) Foerfarande foer framstaellning av isoxazol- och furanderivat.
FI861444A7 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara hydroxamater.
FI862377A0 (fi) Avlaegsning av skyddsgrupper av allylestrar och -etrar.
FI862585A7 (fi) Foerfarande foer framstaellning av polyolefiner.
FI850090A0 (fi) Foerfarande foer framstaellning av naturstensimitationer.
FI861211L (fi) Anordning foer oevervakning av funktionen av lagringar.
FI855169L (fi) Vaotpress foer avlaegsnande av vatten fraon en fiberbana.
FI861006A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva etrar.
FI850951L (fi) Foerfarande foer framstaellning av kisel.
FI863069L (fi) Foerfarande foer upploesande av lignocellulosa.
FI862557L (fi) Foerfarande foer framstaellning av en dibromnitrofoerening.
FI860872A7 (fi) Foerfarande foer framstaellning av klordioxid.
FI864431A0 (fi) Foerfarande foer framstaellning av dopamin- -hydroxylasinhibitorer.
FI854469A0 (fi) Foerfarande foer framstaellning av vaextfiberbaserade skivor.
FI854628L (fi) Foerfarande foer kausticering av en alkalikarbonathaltig vattenloesning.
FI862278A0 (fi) Foerfarande foer framstaellning av 11- substituerade steroider.
FI860957L (fi) Foerfarande foer foersnabbande av fixeringen av kromathaltiga traeskyddssalter.
FI861238A7 (fi) Foerfarande foer framstaellning av kinolin-3-karboxylsyror.
FI862279A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-fenyl-4-fenyl-1 -piperazinkarboxamidderivat.
FI861928A7 (fi) Foerfarande foer tillverkning av verktyg foer bearbetning av foerdjupningar.
FI862770A7 (fi) Anordning foer laecktestning av delar.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SMITHKLINE BECKMAN CORPORATION